Assessing, maintaining and/or restoring viability of organs/tissues
US11490615B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2012 |
| Grant date | Nov 8, 2022 |
| Priority date | — |
| Expiry date | Jun 7, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01N1/143
- WIPO fieldBasic materials chemistry
- WIPO sectorChemistry
Abstract
Methods for ex vivo perfusion of organs (and/or tissues) with a perfusate designed to condition the organ with the desired effect being that upon transplant, said organ, having been administered said perfusate, is less likely to experience delayed graft function, deleterious effects of ischemia/reperfusion injury, including inflammatory reactions, and/or other detrimental responses that can injure the organ or recipient including precipitating or enhancing an immunological reaction from the recipient with the potential of compromising the graft's and/or recipients short teen and/or long term health and proper functionality while monitoring, sustaining and/or restoring the viability of the organ and preserving the organ for storage and/or transport.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.